2025 ICD-10-CM code C90.11
(Active) Effective Date: N/A Malignant neoplasms of lymphoid, hematopoietic and related tissue - Plasma cell leukemia in remission 2 (Neoplasms) Feed
Plasma cell leukemia is a type of cancer affecting plasma cells in the bone marrow.This code signifies it is currently in remission.
Coding C90.11 accurately reflects the patient's current disease status and guides ongoing management and surveillance.It is crucial for tracking treatment outcomes and for determining the appropriateness of future interventions if the disease relapses.
Diagnosis and treatment are managed by hematologists/oncologists.Diagnostic workup includes blood tests, bone marrow biopsy, imaging studies (CT, MRI, PET). Treatment options may include chemotherapy, radiation, stem cell transplantation, or watchful waiting.
- 2 (Neoplasms)
- Malignant neoplasms (C00-C97)Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
In simple words: This code means that a person's plasma cell leukemia, a blood cancer, is currently not showing any signs or symptoms.
Plasma cell leukemia in remission. This indicates that the individual had previously been diagnosed with plasma cell leukemia, a cancer of the plasma cells, and that the signs and symptoms of the disease are currently absent.
Example 1: A patient with a history of plasma cell leukemia undergoes regular blood work and imaging. The results show no detectable cancer cells, and the patient has no symptoms. C90.11 is used to indicate remission., A patient completed treatment for plasma cell leukemia six months ago. Follow-up tests indicate no signs of active disease. C90.11 is used., A patient achieved remission after stem cell transplantation for plasma cell leukemia. Ongoing monitoring shows continued absence of disease activity, and C90.11 is used to report the remission status.
Documentation should include details of the initial diagnosis, treatment history, and the most recent evaluations showing the absence of signs and symptoms.Supporting reports from blood tests, bone marrow biopsy, and imaging studies should be available.
- Payment Status: Active
- Specialties:Hematology, Oncology
- Place of Service:Inpatient Hospital, On Campus-Outpatient Hospital, Office, Independent Clinic, Federally Qualified Health Center